Pacira BioSciences Q4 Earnings Assessment
Benzinga Insights 8 months ago
Earnings
Pacira BioSciences (NASDAQ:PCRX) just disclosed its Q4 earnings on Thursday, February 26, 2026 at 04:00 PM.
Here's a brief overview of the earnings report.
Earnings
Pacira BioSciences missed estimated earnings by -26.92%, reporting an EPS of $0.57 versus an estimate of $0.78.
Revenue was up $9.62 million from the same period last year.
Past Earnings Performance
In the previous quarter, the company beat on EPS by $0.14, resulting in a 4.5% increase change in the share price the following day.
Here's a look at Pacira BioSciences's past performance:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | 0.56 | 0.62 | 0.60 | 0.83 |
| EPS Actual | 0.70 | 0.74 | 0.62 | 0.91 |
| Revenue Estimate | 182.38M | 183.35M | 175.88M | 185.38M |
| Revenue Actual | 179.52M | 181.10M | 168.92M | 187.25M |
To track all earnings releases for Pacira BioSciences visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.